Zurück
  • Short Talk
  • S-6-5

A randomized controlled phase II clinical trial assessing pharmacokinetics of favipiravir for the treatment of Lassa fever

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Lecture hall

Session

Tropical and Emerging Infections

Thema

  • Tropical and Emerging Infections

Mitwirkende

Dr. Mirjam Groger (Hamburg/ DE), Kevin Okwaraeke (Owo/ NG), Peter Akhideno (Irrua/ NG), Dr. Meike Pahlmann (Hamburg/ DE), Christine Kleist (Hamburg/ DE), Cédric Mbavu (Hamburg/ DE), Julia Hinzmann (Hamburg/ DE), Veronika Schlicker (Hamburg/ DE), Oluwasola Femi Babatunde (Irrua/ NG), Dr. Ndapewa Ithete (Hamburg/ DE), Osahogie Edeawe (Irrua/ NG; Ekpoma/ NG), Francisca Sarpong (Hamburg/ DE), Camille Fritzell (Bordeaux/ FR; Abidjan/ CI; Dakar/ SN), Alexandre Duvignaud (Bordeaux/ FR; Abidjan/ CI), Denis Malvy (Abidjan/ CI; Bordeaux/ FR), Prof. Sylvanus Okogbenin (Irrua/ NG), Marie Jaspard (Dakar/ SN; Bordeaux/ FR; Abidjan/ CI), Dr. Sophie Duraffour (Hamburg/ DE), Dr. Lisa Oestereich (Hamburg/ DE), Prof. Sebastian G. Wicha (Hamburg/ DE), Prof. Dr. Stephan Günther (Hamburg/ DE), Michael Ramharter (Hamburg/ DE), Oluwafemi Ayodeji (Owo/ NG), Cyril Erameh (Irrua/ NG)

  • © Conventus Congressmanagement & Marketing GmbH